Daniel M Geynisman Selected Research

Ipilimumab

1/2023	Comparative Effectiveness of Front-Line Ipilimumab and Nivolumab or Axitinib and Pembrolizumab in Metastatic Clear Cell Renal Cell Carcinoma.
3/2022	Temporal trends of adverse events and costs of nivolumab plus ipilimumab versus sunitinib in advanced renal cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel M Geynisman Research Topics

Disease

38	Neoplasms (Cancer) 05/2024 - 07/2012
19	Renal Cell Carcinoma (Grawitz Tumor) 01/2023 - 12/2014
15	Urinary Bladder Neoplasms (Bladder Cancer) 05/2024 - 12/2015
15	Carcinoma (Carcinomatosis) 05/2024 - 06/2017
12	Prostatic Neoplasms (Prostate Cancer) 10/2023 - 11/2012
4	Disease Progression 10/2022 - 01/2013
3	Neoplasm Metastasis (Metastasis) 09/2022 - 01/2018
3	Pathologic Complete Response 01/2021 - 05/2018
3	Penile Neoplasms (Penile Cancer) 03/2019 - 01/2018
2	COVID-19 11/2022 - 09/2021
1	Injection Site Reaction 01/2023
1	Ovarian Neoplasms (Ovarian Cancer) 01/2023
1	Anemia 01/2023
1	Non-Muscle Invasive Bladder Neoplasms 01/2023
1	Nutrition Disorders (Nutritional Disorders) 07/2022
1	Hemic and Lymphatic Diseases 07/2022
1	Infections 01/2022
1	Overweight 01/2022
1	Pyelonephritis 01/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2021
1	Urinary Tract Infections (Urinary Tract Infection) 01/2021
1	Angiomyolipoma 09/2020
1	Tuberous Sclerosis (Bourneville's Disease) 09/2020
1	Lymphatic Metastasis 03/2019
1	Kidney Neoplasms (Kidney Cancer) 12/2018
1	Fatigue 01/2018
1	Hand-Foot Syndrome 01/2018
1	Diarrhea 01/2018
1	Melanoma (Melanoma, Malignant) 10/2017
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2017
1	Turcot syndrome 09/2017

Drug/Important Bio-Agent (IBA)

11	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 05/2018
10	Immune Checkpoint InhibitorsIBA 12/2023 - 12/2014
8	NivolumabIBA 01/2023 - 11/2015
6	pembrolizumabIBA 01/2023 - 09/2017
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2014
4	cabozantinibIBA 01/2023 - 01/2019
4	Sunitinib (Sutent)FDA Link 07/2022 - 01/2018
3	Axitinib (AG 013736)IBA 01/2023 - 01/2020
3	atezolizumabIBA 01/2023 - 09/2017
2	Docetaxel (Taxotere)FDA Link 10/2023 - 10/2019
2	Abiraterone AcetateIBA 10/2023 - 03/2022
2	VaccinesIBA 01/2023 - 01/2013
2	Vinblastine (Vinblastine Sulfate)FDA Link 01/2023 - 12/2022
2	IpilimumabIBA 01/2023 - 03/2022
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 12/2022
2	Methotrexate (Mexate)FDA LinkGeneric 01/2023 - 12/2022
2	Androgen Receptors (Androgen Receptor)IBA 01/2023 - 12/2016
2	Gemcitabine FDA Link 12/2022 - 05/2018
2	Programmed Cell Death 1 ReceptorIBA 01/2016 - 11/2015
1	PentosesIBA 04/2024
1	Phosphates (Orthophosphate)IBA 04/2024
1	Fatty Acids (Saturated Fatty Acids)IBA 04/2024
1	avelumabIBA 03/2024
1	rucaparibIBA 01/2023
1	Interferon-gamma (Interferon, gamma)IBA 01/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2023
1	durvalumabIBA 01/2023
1	enfortumab vedotinIBA 01/2023
1	guadecitabineIBA 01/2023
1	ipatasertibIBA 01/2023
1	PROSTVACIBA 01/2023
1	Flutamide (Eulexin)FDA LinkGeneric 01/2023
1	LigandsIBA 01/2023
1	Glutamic Acid (Glutamate)FDA Link 10/2022
1	Glutamine (L-Glutamine)FDA Link 10/2022
1	EnzymesIBA 10/2022
1	bempegaldesleukinIBA 10/2022
1	GlutaminaseIBA 10/2022
1	COVID-19 VaccinesIBA 01/2022
1	Metformin (Glucophage)FDA LinkGeneric 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Testosterone (Sustanon)FDA Link 01/2022
1	bicalutamide (Casodex)FDA LinkGeneric 01/2022
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2022
1	EpitopesIBA 12/2021
1	Everolimus FDA Link 09/2020
1	PlatinumIBA 01/2020
1	abirateroneIBA 10/2019
1	AndrogensIBA 10/2019
1	Hormones (Hormone)IBA 10/2019
1	Genetic Markers (Genetic Marker)IBA 12/2018

Therapy/Procedure

39	Therapeutics 12/2023 - 07/2012
12	Drug Therapy (Chemotherapy) 05/2024 - 07/2015
12	Immunotherapy 04/2024 - 01/2013
11	Neoadjuvant Therapy 05/2024 - 05/2018
10	Cystectomy 01/2023 - 10/2016
5	Radiotherapy 01/2023 - 01/2017
4	Castration 01/2023 - 11/2012
3	Lymph Node Excision (Lymph Node Dissection) 01/2021 - 01/2018
2	Drug Tapering 05/2023 - 01/2018
2	Time-to-Treatment 11/2022 - 09/2021
2	Nephrectomy 01/2022 - 01/2016
1	Treatment Delay 12/2023
1	Aftercare (After-Treatment) 01/2023
1	Combination Drug Therapy (Combination Chemotherapy) 01/2023
1	Brachytherapy 01/2022
1	Stents 01/2022
1	Nephroureterectomy 01/2021
1	Adjuvant Chemotherapy 03/2019